Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (121-130 of 338) with videos related to

Pageof 34
Sort By:
Circulation|September 1, 1995
Nifedipine and mortality. Grave defects in the dossierL H Opie, F H Messerli
American Heart Journal|January 1, 1992
Determinants of ventricular ectopy in hypertensive cardiac hypertrophyR E Schmieder, F H Messerli
The American Journal of Medicine|September 26, 1983
Left ventricular hypertrophy--good or evil?F H Messerli, R B Devereux
Journal of Human Hypertension|April 25, 2008
Treatment of hypertensive emergencies: blood pressure cosmetics or outcome evidence?F H Messerli, D J Eslava
Lancet (London, England)|October 6, 1998
Framingham at 50F H Messerli, B S Mittler
Journal of the American College of Cardiology|August 1, 1996
Central blood volume: an explanation of racial differences in left ventricular mass?R F Gillum, F H Messerli
Journal of Clinical Hypertension|September 1, 1986
Cardiodynamics of hypertension: a guide to selection of therapyF H Messerli, G E Garavaglia
Journal of Human Hypertension|March 1, 1994
Optimal titration of ACE inhibitorsM R Weir, F H Messerli
Deutsche Medizinische Wochenschrift (1946)|June 23, 1995
[The compliance of the large elastic arteries after blood pressure-lowering therapy with a calcium antagonist]R E Schmieder, F H Messerli
Circulation|May 1, 1993
Does obesity influence early target organ damage in hypertensive patients?R E Schmieder, F H Messerli
Pageof 34

Showing results (121-130 of 338) with videos related to

Sort By:
Pageof 34
Circulation|September 1, 1995
Nifedipine and mortality. Grave defects in the dossierL H Opie, F H Messerli
American Heart Journal|January 1, 1992
Determinants of ventricular ectopy in hypertensive cardiac hypertrophyR E Schmieder, F H Messerli
The American Journal of Medicine|September 26, 1983
Left ventricular hypertrophy--good or evil?F H Messerli, R B Devereux
Journal of Human Hypertension|April 25, 2008
Treatment of hypertensive emergencies: blood pressure cosmetics or outcome evidence?F H Messerli, D J Eslava
Lancet (London, England)|October 6, 1998
Framingham at 50F H Messerli, B S Mittler
Journal of the American College of Cardiology|August 1, 1996
Central blood volume: an explanation of racial differences in left ventricular mass?R F Gillum, F H Messerli
Journal of Clinical Hypertension|September 1, 1986
Cardiodynamics of hypertension: a guide to selection of therapyF H Messerli, G E Garavaglia
Journal of Human Hypertension|March 1, 1994
Optimal titration of ACE inhibitorsM R Weir, F H Messerli
Deutsche Medizinische Wochenschrift (1946)|June 23, 1995
[The compliance of the large elastic arteries after blood pressure-lowering therapy with a calcium antagonist]R E Schmieder, F H Messerli
Circulation|May 1, 1993
Does obesity influence early target organ damage in hypertensive patients?R E Schmieder, F H Messerli
Pageof 34